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Abstract Protegrin 1 (PG-I) is a naturally occurring cationic 
antimicrobial peptide that is 18 residues long, has an aminated 
carboxy terminus and contains two disulphide bridges. Here, we 
investigated the antimicrobial activity of PG-I and three linear 
analogues. Then, the membrane permeabilisation induced by 
these peptides was studied upon Xenopus laevis oocytes by 
electrophysiological methods. From the results obtained, we 
concluded that protegrin is able to form anion channels. 
Moreover, it seems clear that the presence of disulphide bridges 
is a prerequisite for the pore formation at the membrane level and 
not for the antimierobial activity. 
K,'y words: Protegrin; Antimicrobial peptide; Disulphide 
b~,nd; Membrane permeabilisation; Ionic channel 
I. Introduction 
Protegrins are five antimicrobial peptides (PG-1 to PG-5, 
Ttble 1) isolated from porcine leukocyte cells [1-3]. These 
s lort  and cationic peptides present two disulphide bridges 
(( ys6-Cys 15 and CysS-Cys 13) [3], and share some sequence 
si~nilarities with mammalian defensins and tachyplesins (Table 
1 ~ [4,5]. We recently reported the solid-phase synthesis and the 
s< lution structure of PG-1, which consists of two antiparallel 
st "ands (Leu 5 ~ Arg 9 and Phe 12 ~ Va116) linked by a distorted 
13-turn (Arg 9 ~ Phe 12) (Aumelas et al., in press). Like all other 
aJJtibiotic peptides, protegrins possess an amphipathic struc- 
tt~re in which the positively charged residues are spatially sep- 
a~ ated from the hydrophobic ones. Several studies indicate 
that host defence peptides, whatever may be their structure 
(~ mphipathic helix, 13-sheet or a mixture of these two motifs), 
aL t by direct lysis of the pathogenic cell membranes. As 
p,,inted out by Maloy and Kari [5], their basic nature facil- 
itates their interaction with the cell membrane and their am- 
phipathic character allows them to be incorporated into the 
membrane, ultimately disrupting its structure ither by forma- 
ti,m of pores or by alteration of the bilayer fluidity [6,7]. 
In the present study, we examine the antimicrobial activity 
o several synthetic protegrin analogues. Using Xenopus laevis 
o~cytes, we show that PG-1 is able to alter the cellular mem- 
b', ane permeability by forming ionic pores that present some 
Sl ecific properties in common with human defensin-induced 
cl annels [8]. Then, using a set of analogues, we demonstrated 
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cysteine bridges to be an absolute prerequisite for membrane 
permeability alteration but not for antimicrobial activity. 
2. Materials and methods 
2.1. Peptide synthes& 
The sequence of the protegrin synthesised corresponds to Protegin-1 
[2]. Peptide synthesis was carried out on a fluorenemethoxycarbonyl 
(Fmoc) PAL-PEG resin, or a Fmoc Arg(Pmc)-PEG resin (Millipore), 
by Fmoc strategy on an automatic apparatus (9050 Pepsynthesiser, 
Milligen). Peptide synthesis was performed as described elsewhere [9]. 
Then, the crude peptide-amide was precipitated with ether, filtered 
and dried in a desiccator. 
2.2. Disulphide bridge formation and peptide pur!fication 
Each crude peptide was purified by reversed-phase high performance 
liquid chromatography (HPLC, Dpack C18 10 ~tm, 20 mm × 250 mm) 
using a linear gradient of 0-60% acetonitrile in0.1% trifluoroacetic a id 
(TFA). The disulphide bridge formation was performed on PG-I and 
PG-1OH as described by Tam et al. [10]. This protocol yielded almost 
100% of peptide preparation oxidised in the correct configuration. The 
disulphide pattern was resolved by NMR in H~O and dimethyl sulph- 
oxide (DMSO), and the CysS-Cys 13 and Cysr-Cys 15 bonds were clearly 
identified (Aumelas et al., in press). Briefly, 120 mg of crude peptide 
was diluted in 150 ml of dissolving buffer (50% H20, 50% 2-propanol, 
pH 5.5). Then, the peptide solution was added slowly (1 ml/min) by 
peristaltic pump into a 0.1 M Tris(hydroxymethyl)aminomethane 
(Tris) solution (400 ml) containing 25% DMSO, and 10% 2-propanol 
at pH 6.85. At the completion of the reaction, the oxidation mixture 
was acidified with TFA to pH 3, and then folded peptides were purified 
as described above. Treatment of purified folded peptide by Ellman's 
reagent showed the absence of free SH groups. After hydrolysis with 
HC1, 6 N in evacuated sealed tubes at I10°C for 24 h, the amino acid 
analysis confirmed the good composition of the peptide. The mass 
spectrometry (Electrospray ionisation on a Fisons Instrument) of 
unfolded or oxidated protegrin analogues was in agreement with the 
expected structure, 2159 +_ 1.75 Da and 2155 + 1.89 Da, respectively. 
2.3. Biological assays 
Antimicrobial activities of synthetic PG-1 analogues were deter- 
mined by microdilution technique against one Gram-negative bacillus 
(E. toll ATCC: 25922) and two Gram-positive cocci (S. aureus, 
ATCC: 25923 and S. epidermidis, ATCC: 12228). Peptide stock solu- 
tions were made in water containing 0.01% acetic acid and then filter 
sterilised. For microdilution technique, wells of a sterilised tray were 
incubated with a final volume of 100 /.tl of 106 CFU/ml organism 
suspensions in Mueller-Hinton broth (Sanofi, France) and serial 2- 
fold dilutions of peptide (from 256 ~tg to 0.125 p_g). The minimal 
inhibitory concentration (MIC) was determined after 24 h incubation 
at 37°C by measuring absorbance. The MIC is defined as the dose at 
which 100% inhibition of growth was observed. Then, the minimal 
concentration of peptide showing 100% bactericidal activity (MBC) 
was determined by incubating a 10 ~tl aliquot from each well onto a 
Mueller-Hinton plate. Results were interpreted after 24 h incubation 
at 37°C. Each MIC and MBC was determined from two independent 
experiments performed in triplicate. 
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Table 1 
Sequence alignment of protegrins (PG-1-5), rabbit defensin (NP-3a), 
human defensin (HNP-1) and tachyplesin (TP-1) as proposed by 
Kokryakov et al. [1] 
PG-1 
PG-2 
PG-3 
PG-4 
PG-5 
NP-3a 
HNP-1 
TP-1 
RGGRLCYCB/~RFCVCVGR 
RGGRLCYCRRRFCICV 
RGGGLCYCRRRFCVCVGR 
RGGRLCYCRGWICFCVGR 
RGGRLCYCRPRFCVCVGR 
GICACRRRFCPNSERFSGYCRVNGARYVRCCS 
ACYCRIPACIAGERRYGTCIYQGRLWAFCC 
KWCFRVCYRGICYRRCR 
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Table 2 
Chemical structures of protegrin analogues used in this study 
PC,..I PG-IOH 
i l  I J i l  | J 
RGGR LCYCR RRFCV CVGR-CONIt2 RGGR LCYCR RRFCV CVGR-COOE[ 
~, .c~c~ ~v cv~o~.~ ~c~ ~c ,~ ~ cv~o~ 
! / 
Acm Acm 
r_P~l  P~lAcm 
2.4. Oocyte preparation and electrophysiological recordings 
Oocytes (stage V-VI) were removed from mature Xenopus laevis 
females (Elevage de Lavalette, Montpellier, France), and separated 
as described elsewhere [11]. After complete separation, oocytes were 
extensively washed in a recovery solution (ND96) containing (in 
mM): 96 NaC1, 2 KCI, 1 MgC12, 1.8 CaCI2, 5 4-(2-hydroxyethyl)-l- 
piperazineethanesulphonic acid (HEPES), pH = 7.6. Complete defol- 
liculation was verified by visual inspection under a stereomicroscope. 
Double-electrode voltage clamp experiments were performed employ- 
ing the Gene Clamp amplifier (Axon, Burlingame). Data were col- 
lected using a TL-1 DMA interface, and stored in an IPC 486 perso- 
nal computer. Off-line data analysis was carried out with version 6 of 
pCLAMP software. We used standard intracellular electrodes with a 
resistance of 0.5 MfZ, when filled with a solution containing (in mM): 
2800, CsCI; 10, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic 
acid (BAPTA); 10, Hepes; adjusted to pH = 7.2, with CsOH. Oocytes 
were then bathed in a 50 I11 recording chamber. When testing pep- 
tides, the perfusion device was arrested, and the peptide-containing 
solution added to the bath. Protegrin-induced changes in membrane 
conductance were measured as the ratio between the conductance in 
control condition (go), and its maximal value during protegrin super- 
fusion (gl). In order to characterise the protegrin-induced membrane 
permeability, we used a set of solutions with different ionic composi- 
tion. We started from a basic solution containing (in mM): Hepes 10, 
MgC12 1, pH = 7.2. 100 mM of either NaC1, KC1, LiC1, CsC1, tetra- 
ethylammoniumchloride (TEA-C1), or choline-chloride (ChCI) was 
then added as required. Intracellular injection of BAPTA was per- 
formed to ensure blockade of the endogenous Ca~+-activated C1- 
current [11]. The BAPTA-containing solution had the following com- 
position (mM): BAPTA free acid 100, CsOH 10, Hepes 10, pH = 7.2. 
Intracellular concentration of BAPTA was estimated to be about 
2-5 mM. All experiments were performed at room temperature (20- 
22°C). 
3. Results and discussion 
3.1. Peptide synthesis and antibacterial activities 
In order to determine the structure-function relations of 
protegrins, we synthesised an aminated peptide corresponding 
to PG-1, an analogue with a COOH-terminal arginine c~-car- 
boxylated (PG-1OH), a linear analogue (r_PG-1) with re- 
duced cysteines, and one derivative (PG-1Acm) in which the 
four SH groups were protected with acetamidomethyl (Acm) 
groups (Table 2). Cysteine oxidation of PG-1 and PG-1OH 
was performed in the presence of DMSO using the protocol 
developed by Tam et al. [10], which allowed us to produce 
synthetic protegrins with a good yield (>59%). It is worth 
noting that in the absence of DMSO no disulphide bridge 
formation was observed after a few days, for a pH range 
from 6 to 7.5. As determined by NMR studies, the PG-1 
and PG-1OH showed only one type of cysteine connection, 
which corresponds to the pattern in the natural product 
(Cys 6 "-') Cys 15, Cys 8 ~ Cys 13) (Aumelas et al., in press). Using 
a microdilution technique, the antimicrobial activity of pep- 
tide analogues was evaluated with S. aureus (ATCC: 25923), 
S. epidermidis (ATCC: 12228), and E. coli (ATCC: 25922) as 
test organisms, and the MIC and the MBC of each peptide 
were determined (see section 2.3). As shown in Table 3, PG-1 
and PG-1OH present the same potency to inhibit bacterial 
proliferation as judged by their MIC values. However, PG- 
1OH is less bactericidal (2-fold) than PG-1 against all types of 
bacteria tested (MBC values), r_PG-1 has a decreased potency 
against the Gram-positive S. epidermidis, the most sensitive 
bacteria used in this work, but this analogue was as efficient 
as PG-1OH against the Gram-positive S. aureus, and most 
powerful against he Gram-negative E. coli. 
By contrast, PG-1Acm shows a very low antimicrobial ac- 
tivity against he two Gram-positive bacteria tested. Interest- 
ingly, this analogue is still as bactericidal as PG-1 against he 
Gram-negative E. coli. Taken together, these data indicate 
that modification of the C-terminal CONH2 group for a neg- 
Table 3 
Antibacterial ctivity of synthetic PG-1 analogues against Gram-negative and Gram-positive bacteria tested with the microdilution technique 
(n = 3 from two independent experiments) 
E. coli (Gram-negative) S. aureus (Gram-positive) S. epidermidis (Gram-positive) 
MCI (I.tg/ml) MCI (I.tg/ml) MCI (Ixg/ml) 
MCB (I.tg/ml) MCB (~tg/ml) MCB (p_g/ml) 
PG-1 64 64 2 
128 128 2 
PG-1OH 64 64 2 
256 256 4 
r_PG-1 32 64 16 
64 256 32 
PG-1Acm 32 512 128 
128 >512 128 
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Fi~. 1. A: Time course and reversibility of membrane permeability change in an oocyte superfused with PG-1 20 lag/ml. Membrane permeabil- 
it~ was studied by application of a 375 ms voltage ramp from -60 to +30 mV, from an holding potential of -80 mV. Numbers on traces indi- 
cate the time (in seconds) after start of protegrin perfusion. Current reversal potential was -16 mV. B: Membrane conductance increment for 
an oocyte that has been superfused with incremental concentrations of PG-1. 
atively charged group (COOH) slightly (2-fold) decreases the 
antimicrobial activity of PG-1. This observation is in good 
accordance with a study dealing with the antimicrobial activ- 
it x of dermastin peptides [12]. On the other hand, the cap- 
abdity of r_PG-1, but not PG-1Acm, to kill Gram-positive 
bacteria suggests that free SH group cysteines, possibly 
through disulphide bridge formation during the experiment, 
ar~ necessary to exert antimicrobial activity against such 
Gram-positive bacteria. Interestingly, disulphide bridges 
seem not to play a crucial role against Gram-negative bacter- 
ia. because both r-PG-1 and PG-1Acm were highly active 
against E. coli. 
3.2. Change in membrane current induced by synthetic PG-1 in 
Xenopus laevis oocytes 
The effect of synthetic protegrins on membrane permeabil- 
ity was investigated in a set of pilot experiments carried out in 
ND96 extracellular solution. As shown in Fig. 1A, PG-1 ap- 
plication induced a continuous increase in membrane perme- 
ability following superfusion at 20 ~tg/ml. For the example 
shown in Fig. 1A, the total oocyte membrane conductance 
was increased almost 10-fold (gl/go ratio was 9.67, as meas- 
ured 10 s before protegrin application, and at 250 s during 
protegrin superfusion). Typical recordings (see Fig. 1A) 
showed a non-linear, slightly outward-rectifying current wave- 
Ta t~le 4 
Summary of the action of synthetic protegrins on the oocyte membrane conductance at different doses 
PG-1 PG-1OH r_PG1 PG-1Acm PG-1 + DTT(1.5 mM) 
]O I,tg/ml + + 
n = 4/4 n = 8/8 
20 ~tg/ml + + 0 
n=5/5 n=8/8 n=6/6 
50 ~tg/ml ++ 0 
n = 3/3 n = 3/3 
I 0" ktg/ml + 
n = 7/7 
20q) lag/ml ++ 
n = 5/5 
Er,~ (mV) -18.1 +0.68 -16+0.77 -15.9+0.4 
n=8 n=13 n=8 
0 
n = 3/3 
0 
n = 5/5 
0 
n = 6/6 
0 
n=6/6 
Symbols (0, +, ++) indicate conductance ratios (gllgo, see section 2) of <2, 25-50, >50. 
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Fig. 2. Lack of voltage dependence for the change in membrane conductance induced by PG-1 20 ~tg/ml with respect o ramp polarity. The fig- 
ures shows an experiment performed on an oocyte that had been bathed in the PG-l-containing solution, rinsed and subsequently exposed to a 
new round of peptide perfusion while applying a voltage ramp of inverted polarity. The protegrin-induced current reversal potentials were -11 
and -9  mV in (A) and (B) respectively. 
form during ramp application, and the presence of an inward 
tail current following return to -80  mV. Current reversal 
potential was constant after the onset of PG-1 effect (see Ta- 
ble 4), and independent of the membrane current amplitude. 
The PG-1 effect was always reversible for all doses and extra- 
cellular ionic conditions tested. When long PG-1 superfusion 
was applied, no steady-state PG-1 effect could be reached, and 
protegrin-induced changes in membrane conductance rapidly 
overcame the compliance of the voltage clamp amplifier (see 
for example Fig. 1B). Fig. 1B shows the change in membrane 
conductance of a test oocyte during applications of increasing 
concentrations of PG-1. In this case, no effect was observed at 
2 ~tg/ml, and a full effect was observed at 20 ktg/ml. We then 
studied the change in membrane conductance induced by PG- 
1OH. Only a slight difference was observed between the two 
folded protegrin analogues, with respect o the minimal pep- 
tide quantity able to induce a significant change in membrane 
conductance. Indeed, PG-1 gave a detectable effect at 3 ~tg/ml 
(n = 3), and PG-1OH showed a concentration threshold at 
about 5 ug/ml. The membrane conductance increment induced 
by PG-1 at 3 ~tg/ml showed slower kinetics of onset, but the 
time course of membrane recovery upon washing did not seem 
to be altered compared to that observed at 20 ktg/ml (data not 
shown). 
These observations uggest that synthetic protegrins are 
capable of changing membrane permeability by forming 
pores. In light of previous reports dealing with natural defen- 
sins [8], where voltage-dependent ionic channel formation has 
been described, we checked for the effect of membrane voltage 
on protegrin-induced membrane conductance. In particular, 
we were interested to see if folded protegrins are able to 
form functional channels in the oocyte membrane at positive 
holding potentials. Fig. 2 shows an example of an experiment 
where the voltage protocol has been inverted in polarity. Even 
when held at +30 mV, PG-1 (20 ~tg/ml) was still able to in- 
crease membrane permeability (Fig. 2B, see legend). Current 
reversal potential did not significantly change upon inversion 
of the ramp polarity, thus confirming that the same type of 
conductance is in fact responsible for the protegrin-induced 
change in membrane permeability observed using the two dif- 
ferent protocols. After inversion of the ramp polarity, partial 
reversibility was still observed after peptide washing, and a 
subsequent round of protegrin perfusion could be successfully 
performed. 
3.3. Role of disulphide bridges 
To investigate the influence of protegrin folding on its bio- 
physical action, we carried out experiments, where the com- 
plete set of folded and linear peptides was used (Table 2). The 
results are summarised in Table 4. In a first batch of oocytes, 
the two folded peptides were able to induce an increment in 
membrane conductance in the concentration range between 
5 and 20 ~g/ml. In contrast, the linear peptide (r_PG-1) 
showed a concentration threshold about 20 times higher (see 
Table 4). Indeed, a significant change in membrane conduc- 
tance was observed only for concentrations around 100 ~g/ml, 
although a slight effect was sometimes observable at 50 txg/ml 
(Table 4). These observations strongly suggest that disulphide 
bridges are a prerequisite for pore formation. The effect of the 
linear peptide at high concentrations could be related to slight 
spontaneous cysteine oxidation close to the oocyte membrane. 
To test this hypothesis, in a separate batch of oocytes, we 
compared the action of r_PG-1 to that of PG-1Acm. In this 
case, we were unable to find a significant increase in mem- 
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Fig. 3. A: Current-voltage r lations for the PG-l-induced (20 gg/ml) membrane current for the voltage range from -60 to +30 mV, in an 
oocyte bathed in different extracellular solutions (see section 2). Current reversal potentials were -15.9, -3 and -21 mV for the NaCI, KC1 
and ChCI solutions respectively. B: Ca 2+ permeation i an oocyte superfused with PG-1. a: Protegrin-induced current in control condition. 
b: Same oocyte after intracellular injection of a BAPTA-containing solution (see section 2). 
brane conductance up to 200 gg/ml upon perfusion of PG- 
1Acm (see Table 4). Moreover, the activity of PG-1 (100 lag/ 
m)  was completely blocked in the presence of 1.5 mM of 
di~hiothreitol (DTT), which confirms the necessity of disul- 
pt-dde bridges in membrane permeability activity of the prote- 
grins. 
3. 1. Ionic characteristic of protegrin-induced membrane current 
Upon superfusion with PG-1 in extracellular ND96 solu- 
ti,,n, current reversal potential is close to the equilibrium po- 
re ltial for C1- ions ([13], see Table 4). This led us to hypothe- 
si,.e that PG-1 can form anionic channels. However, even 
classical anionic channels can also pass small cations moder- 
ately well [14]. This is the case, for example, for insect defen- 
sin-induced channels [8]. Fig. 3 shows an experiment where an 
o, ,cyte has been challenged with three rounds of PG-1 super- 
fi~sion, in three different extracellular cation-containing solu- 
tiaras, while keeping the chloride concentration constant. 
t pon superfusion with PG-1, current reversal potentials 
~,~'re -16, -5.5-+ 1.8, and -21 mV, for the NaC1, KC1, and 
C 1C1 solutions in n = 3 oocytes, respectively. We were able to 
c, ,nfirm these observations in another set of experiments, em- 
pioying other cations. Current reversal potentials were: 
-6+3 (n = 3), -8 -  +1 (n =4), 0-+1 (n=3), -9-+1 (n= 3), 
and -11-+ 1 mV (n = 3) for the Li +-, Na +-, K +-, Cs +- and 
T EA+-containing solutions respectively. In contrast, currents 
recorded in the presence of extracellular choline show a re- 
vtrsal potential that almost overlaps that of CI- which sug- 
gests that choline ions are probably too large to permeate the 
channel. These results confirm that small cations, like Na + 
and K +, are indeed able to permeate the pore formed by 
PG-1, together with C1- ions. The consequence is a shift of 
the current reversal potential toward more positive potentials. 
3.5. Calcium permeation through the protegrin-induced 
conductance 
Ca 2+ is an important intracellular messenger, involved in 
many regulatory processes. However, Ca 2- may also induce 
cell death, through cytotoxic actions, as well as apoptosis (see 
for example [15]). In our conditions, two observations suggest 
that calcium permeates the protegrin-induced conductance: 
(1) the reversal potential of the PG-l-induced current shifted 
toward a more positive potential upon switching from extra- 
cellular 1.8 mM Ca 2+ (ND96 solution) to the NaC1 solution 
that lacks extracellular Ca 2+, and (2) PG-l-induced current 
has a linear current-to-voltage relation in the NaCI-, Ca 2+- 
free, extracellular solution. A simple way to account for these 
observations, i  that Ca 2+ permeation activates the endogen- 
ous Ca2+-dependent C1- current [16] during PG-1 application, 
thus leading to the appearance of apparent outward rectifica- 
tion, and the tail current. Fig. 3B shows an experiment where 
PG-1 (20 gg/ml) has been perfused in normal conditions (a), 
and after intracellular injection of BAPTA to block the acti- 
vation of the endogenous C1- current (b). In control condi- 
tions, protegrin-induced current shows the typical outward 
rectification, and a prominent ail current upon return to 
-80 mV. In contrast, after intracellular BAPTA injection, 
the current-to-voltage relation became linear, and the tail cur- 
rent was almost completely suppressed. These observations 
constitute a clear evidence that Ca 2+ ions are in fact able to 
98 
permeate the protegrin-induced pore, thus activating the en- 
dogenous C1- current. Accordingly, current reversal potential 
slightly shifted, upon injection of BAPTA, toward the positive 
direction ( -8  and -5  mV in (a) and (b) respectively). 
4. Conclusion 
A common feature of the defensin or tachyplesin family is 
to present an amphipathic structure constrained by two or 
three disulphide bridges with basic hydrophilic lusters due 
to the presence of cationic side chains [5,6]. Several studies 
indicate that these peptides act by altering the permeability of 
biological membranes. However, the mechanism of the mem- 
brane permeabilisation is not yet well understood. For human 
defensin, it has been suggested that membrane alteration oc- 
curs through peptide aggregation with a solvent channel be- 
tween them. We found that synthetic protegrins form weakly 
selective pores in Xenopus laevis oocytes. Small monovalent 
cations (especially K ÷) as well as Ca 2+ permeate the prote- 
grin-induced pore together with C1-. Despite their size, K ÷ 
ions were particularly favoured, so that in their presence the 
pore became completely unselective. This effect could be ex- 
plained by the existence of steric, K+-specific, rearrangements 
induced by permeation of this ion in the channel pore. Our 
data thus suggest that protegrins and defensins present a sim- 
ilar activity toward the membrane, in the sense that they both 
form weakly selective ionic channels, where anions, as well as 
small cations, are able to permeate ([8,17], this report). How- 
ever, contrary to human and insect defensins [8,17], the pro- 
tegrin-induced membrane conductance does not show voltage 
dependence in the voltage range between -100 and +30. In 
particular, pore formation is not blocked at positive holding 
potentials. The linearity of the current waveform during ramp 
application further suggests that channel permeation is vol- 
tage-independent. We also find that protegrin folding induced 
by disulphide bridges is essential for membrane permeabilisa- 
tion, but not for bactericidal activity (see Table 3). In parti- 
cular, connectivity of disulphide bridges seems not to be re- 
quired for activity against Gram-negative bacteria. Taken 
together, these data suggest hat antimicrobial activity could 
M.E. Mangoni et al./FEBS Letters 383 (1996) 93-98 
exist independently from membrane pore formation. Experi- 
ments are in progress to study the cytotoxic mechanism of 
linear protegrin analogues. 
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